VG Life Sciences Inc. (VGLS)

0.0001 +0.0000 (+100.00%) At close: 03:59PM EDT

VG Life Sciences Inc.

121 Gray Avenue
Suite 200
Santa Barbara, CA 93101
United States
805 879 9000
https://www.vglifesciences.com

Sector(s): Real Estate
Industry: Real Estate - Development
Full Time Employees: 1

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Haig Keledjian	Co-Founder, Chairman, CEO, President, VP of Research & Development, CFO and Secretary	292.5k	N/A	1962
Dr. M. Karen Newell-Rogers	Chief Scientist	N/A	N/A	N/A
Robert A. Forrester	Corporate Counsel	N/A	N/A	N/A
Mr. Robert Berliner B.Sc., J.D.	Consultant & Advisory Board Member	N/A	N/A	N/A

Amounts are as of December 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.

Corporate Governance

VG Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.